Benzinga | Feb 25, 2021 05:06PM EST

ZIOPHARM Oncology Q4 EPS $(0.11) Misses $(0.10) Estimate

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 22.22 percent decrease over losses of $(0.09) per share from the same period last year.